[Trial treatment of gastroduodenal ulcers with pyridine-2-aldoxime methyl methanesulfonate (RP 7676), a cholinesterase reactivator].
D002801:Cholinesterase Reactivators; D006898:Hydroxylamines / Q000628:therapy*; D008741:Methyl Methanesulfonate; D010091:Oximes; D010437:Peptic Ulcer / Q000628:therapy*; D011725:Pyridines / Q000628:therapy*
D002801:Cholinesterase Reactivators; D006898:Hydroxylamines; D010091:Oximes; D011725:Pyridines; C060977:pyridine-2-aldoxime; D008741:Methyl Methanesulfonate
HYDROXYLAMINES/therapy; PEPTIC ULCER/therapy; PYRIDINES/therapy